The Fund aims to achieve capital growth and income from investment in a portfolio of funds managed by Threadneedle Investments.
Name | % Net Assets |
---|---|
United Kingdom Gilt 4.5 07/03/2019 | 1.8% |
BP PLC | 1.8% |
Bundesrepublik Deutschland 3.5 04/07/2019 | 1.8% |
GlaxoSmithKline PLC | 1.7% |
United States Treasury Note/Bond 4.5 15/08/2039 | 1.5% |
Bundesrepublik Deutschland 4.75 04/07/2040 | 1.4% |
Vodafone Group PLC | 1.3% |
Netherlands Government Bond 4 15/07/2019 | 1.3% |
British American Tobacco PLC | 1.3% |
AstraZeneca PLC | 1.2% |
Key | % Net Assets |
---|---|
United Kingdom Gilt 4.5 07/03/2019 | 1.8% |
BP PLC | 1.8% |
Bundesrepublik Deutschland 3.5 04/07/2019 | 1.8% |
GlaxoSmithKline PLC | 1.7% |
Other | 92.9% |
Date | 09-Apr-2021 |
---|---|
Bid | 185.80p |
Offer | 185.80p |
Currency | GBP |
Change | 0.50p |
% | 0.27% |
YTD change | 185.80p |
YTD % | n/a |
Fund Inception | 26/08/1997 |
---|---|
Fund Manager | Sarah Arkle / Alex Lyle |
TER | 1.21 (30-Mar-2012) |
Minimum Investment | |
---|---|
Initial | £500000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.00% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.08 |
You are here: research